4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-22-127883
10% owner bought 2,403,049 shares at an average $5.44 ($13,073,874)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 10% owner | 2022-12-14 | Purchase | +824,600 | $5.46 | $4,501,574 | 7,824,600 | I: show line 1 in the form |
| RA CAPITAL MANAGEMENT, L.P. 10% owner | 2022-12-15 | Purchase | +237,029 | $5.50 | $1,302,474 | 8,061,629 | I: show line 2 in the form |
| RA CAPITAL MANAGEMENT, L.P. 10% owner | 2022-12-16 | Purchase | +1,341,420 | $5.42 | $7,269,826 | 9,403,049 | I: show line 3 in the form |
| Open-market purchases · 2,403,049 sh · avg $5.44 · $13,073,874 | |||||||
Loading xslF345X03/tm2232930-1_4.xml…